Treatment of prolonged ventricular fibrillation. Immediate countershock versus high-dose epinephrine and CPR

J T Niemann1, C B Cairns, J Sharma

  • 1Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance 90509.

Circulation
|January 1, 1992
PubMed

Insights

Early defibrillation for ventricular fibrillation can be ineffective. Providing high-dose epinephrine and cardiopulmonary resuscitation (CPR) before countershock significantly improves cardiac arrest resuscitation outcomes in a canine model.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Veterinary Medicine

Background:

  • Early defibrillation improves cardiac arrest outcomes.
  • Prolonged ventricular fibrillation often leads to asystole or non-perfusing rhythms post-countershock.
  • High-dose epinephrine enhances perfusion during cardiopulmonary resuscitation (CPR).

Purpose of the Study:

  • To compare cardiac resuscitation outcomes between immediate countershock with high-dose epinephrine therapy and conventional CPR before countershock in a canine model of prolonged ventricular fibrillation.

Main Methods:

  • Ventricular fibrillation was induced in 28 dogs.
  • Animals received either immediate countershock followed by advanced cardiac life support (ACLS) or high-dose epinephrine and CPR before countershock and ACLS.
  • Resuscitation outcomes and coronary perfusion pressure were compared between groups.

Main Results:

  • A spontaneous perfusing rhythm was restored in significantly more dogs treated with epinephrine and CPR before countershock (9/14) compared to immediate countershock (3/14).
  • Coronary perfusion pressure before countershock was significantly greater in the epinephrine and CPR group.
  • p = 0.014 for resuscitation success.

Conclusions:

  • A brief period of myocardial perfusion with high-dose epinephrine and CPR before countershock improves cardiac resuscitation outcomes from prolonged ventricular fibrillation.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...